Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-20 · accession 0001823239-23-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-21 | 2023-07-20 | MRVI | DeFord John A | Dir | A - Grant | $0.00 | +31.9K | 31.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-20 | A | A | 31,901 | $0.00 | 31,901 | D | — | — | (F1) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of July 20, 2024, July 20, 2025, and July 20, 2026, subject to the Reporting Person's continued service on the Board of Directors of the Issuer. |